Synopsis
Synopsis
0
KDMF
0
VMF
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
Annual Reports
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cellcristin
2. Citomid
3. Farmistin
4. Leurocristine
5. Oncovin
6. Oncovine
7. Onkocristin
8. Pfs, Vincasar
9. Sulfate, Vincristine
10. Vincasar
11. Vincasar Pfs
12. Vincristin Bristol
13. Vincristin Medac
14. Vincristine
15. Vincrisul
16. Vintec
1. 2068-78-2
2. Kyocristine
3. Vincristine Sulphate
4. Vincrisul
5. Leurocristine Sulfate
6. Oncovin
7. Onkovin
8. Marqibo
9. 22-oxovincaleukoblastine Sulfate
10. Vcr Sulfate
11. Rel-vincristine Sulfate
12. Nsc 67574
13. Lilly 37231
14. Nsc67574
15. Nsc-67574
16. Leurocristine, Sulfate (1:1) (salt)
17. Alkaloid Extracted From Vinca Rosea Linn
18. Novopharm
19. Chebi:79401
20. 1217704-93-2
21. Mls002702994
22. Lilly-37231
23. Vincristini Sulfas
24. Oncovin (lilly)
25. Vincasar (tn)
26. Marqibo (tn)
27. Oncovin (tn)
28. Vincrex (tn)
29. Vincristine, Sulfate
30. Leurocristine, Sulfate
31. Vincristine Sulphate Salt
32. Vincristine Sulfate Liposome
33. Schembl3710
34. Leurocristine Sulfate (1:1)
35. Chembl501867
36. Dtxsid8044331
37. Vincristine Sulfate (jp17/usp)
38. Hms3414l13
39. Hms3678l11
40. Mfcd08706469
41. Akos015895862
42. V0129
43. Lcr
44. Vcr
45. D02197
46. 068v782
47. A936684
48. Methyl (3ar,3a1r,4r,5s,5ar,10br)-4-acetoxy-3a-ethyl-9-((3s,5s,7s,9s)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2h-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-6-formyl-5-hydroxy-8-methoxy-3a,3a1,4,5,5a,6,11,12-octahydro-1h-indolizino[8,1-cd]carbazole-5-carboxylate Sulfate
Molecular Weight | 923.0 g/mol |
---|---|
Molecular Formula | C46H58N4O14S |
Hydrogen Bond Donor Count | 5 |
Hydrogen Bond Acceptor Count | 16 |
Rotatable Bond Count | 10 |
Exact Mass | 922.36702371 g/mol |
Monoisotopic Mass | 922.36702371 g/mol |
Topological Polar Surface Area | 254 Ų |
Heavy Atom Count | 65 |
Formal Charge | 0 |
Complexity | 1830 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 9 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
2 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
3 of 4 | |
---|---|
Drug Name | Marqibo kit |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable, liposomal |
Route | Intravenous |
Strength | 5mg/5ml (1mg/ml) |
Market Status | Prescription |
Company | Talon Therap |
4 of 4 | |
---|---|
Drug Name | Vincristine sulfate pfs |
Active Ingredient | Vincristine sulfate |
Dosage Form | Injectable |
Route | Injection |
Strength | 1mg/ml |
Market Status | Prescription |
Company | Hospira; Teva Pharms Usa |
Antineoplastic Agents, Phytogenic
Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. (See all compounds classified as Antineoplastic Agents, Phytogenic.)
Tubulin Modulators
Agents that interact with TUBULIN to inhibit or promote polymerization of MICROTUBULES. (See all compounds classified as Tubulin Modulators.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
31
PharmaCompass offers a list of Vincristine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Vincristine Sulfate manufacturer or Vincristine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Vincristine Sulfate manufacturer or Vincristine Sulfate supplier.
PharmaCompass also assists you with knowing the Vincristine Sulfate API Price utilized in the formulation of products. Vincristine Sulfate API Price is not always fixed or binding as the Vincristine Sulfate Price is obtained through a variety of data sources. The Vincristine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Marqibo Kit manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Marqibo Kit, including repackagers and relabelers. The FDA regulates Marqibo Kit manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Marqibo Kit API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Marqibo Kit manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Marqibo Kit supplier is an individual or a company that provides Marqibo Kit active pharmaceutical ingredient (API) or Marqibo Kit finished formulations upon request. The Marqibo Kit suppliers may include Marqibo Kit API manufacturers, exporters, distributors and traders.
click here to find a list of Marqibo Kit suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Marqibo Kit DMF (Drug Master File) is a document detailing the whole manufacturing process of Marqibo Kit active pharmaceutical ingredient (API) in detail. Different forms of Marqibo Kit DMFs exist exist since differing nations have different regulations, such as Marqibo Kit USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Marqibo Kit DMF submitted to regulatory agencies in the US is known as a USDMF. Marqibo Kit USDMF includes data on Marqibo Kit's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Marqibo Kit USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Marqibo Kit suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Marqibo Kit Drug Master File in Japan (Marqibo Kit JDMF) empowers Marqibo Kit API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Marqibo Kit JDMF during the approval evaluation for pharmaceutical products. At the time of Marqibo Kit JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Marqibo Kit suppliers with JDMF on PharmaCompass.
A Marqibo Kit CEP of the European Pharmacopoeia monograph is often referred to as a Marqibo Kit Certificate of Suitability (COS). The purpose of a Marqibo Kit CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Marqibo Kit EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Marqibo Kit to their clients by showing that a Marqibo Kit CEP has been issued for it. The manufacturer submits a Marqibo Kit CEP (COS) as part of the market authorization procedure, and it takes on the role of a Marqibo Kit CEP holder for the record. Additionally, the data presented in the Marqibo Kit CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Marqibo Kit DMF.
A Marqibo Kit CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Marqibo Kit CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Marqibo Kit suppliers with CEP (COS) on PharmaCompass.
A Marqibo Kit written confirmation (Marqibo Kit WC) is an official document issued by a regulatory agency to a Marqibo Kit manufacturer, verifying that the manufacturing facility of a Marqibo Kit active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Marqibo Kit APIs or Marqibo Kit finished pharmaceutical products to another nation, regulatory agencies frequently require a Marqibo Kit WC (written confirmation) as part of the regulatory process.
click here to find a list of Marqibo Kit suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Marqibo Kit as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Marqibo Kit API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Marqibo Kit as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Marqibo Kit and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Marqibo Kit NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Marqibo Kit suppliers with NDC on PharmaCompass.
Marqibo Kit Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Marqibo Kit GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Marqibo Kit GMP manufacturer or Marqibo Kit GMP API supplier for your needs.
A Marqibo Kit CoA (Certificate of Analysis) is a formal document that attests to Marqibo Kit's compliance with Marqibo Kit specifications and serves as a tool for batch-level quality control.
Marqibo Kit CoA mostly includes findings from lab analyses of a specific batch. For each Marqibo Kit CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Marqibo Kit may be tested according to a variety of international standards, such as European Pharmacopoeia (Marqibo Kit EP), Marqibo Kit JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Marqibo Kit USP).